Industry updates
Fresenius Kabi set up an antineoplastic drugR&D center in Wuhang
Date:2014-05-11 13:57:31    Viewtimes:34917     

On 6th Sep 2012, Germany company Fresenius Kabi (FK) stated they proposed initial investment of 25 million euros (about 200 million yuan) to set up an R & D center and production base for antineoplastic drug in Wuhan Optical Valley. This is an important part of global business for the introduction of global core pharmaceutical business to China, before that FK's nutrition therapy, infusion therapy and medical equipment had already entered into Chinese market.

Contact us    
All rights reserved (C)2010 Network supported by ChemNet China Global Chemical Network